HR. 946Introduced
ORPHAN Cures Act
Plain-English overview
What this bill does
Modifies Medicare drug price negotiation rules for orphan drugs by changing market approval timing and broadening exclusions for rare disease treatments
Key points
- Modify market approval calculations
- Exclude certain orphan drugs
Current status
Where it stands
Status
Introduced
Latest action
2025-02-06 — Sponsor introductory remarks on measure. (CR H535-536)
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.